JOINT INTERNATIONAL SCIENTIFIC MEETING: "DIABETES MELLITUS. FROM BASIC RESEARCH TO THE DAY-TO-DAY CLINICAL PRACTICE"

Prof. Martin Heni, MD

Martin Heni is a researcher and physician at the University Hospital Tübingen, Germany. He is head of the Clinical Research Center for Diabetes. Furthermore, he is deputy head of the Division for Prevention and Treatment of Diabetes at the IDM of the Helmholtz Center Munich. His research focuses on brain control of human metabolism, the regulation of insulin sensitivity and secretion as well as the pathogenesis and treatment of type 2 diabetes and its’ complications.
Martin Heni received his MD from the Eberhard-Karls-University Tübingen in 2008. Since 2015 he is board certified for Internal Medicine, Endocrinology and Diabetology. In 2018 he was appointed as Professor at the University of Tübingen. He was awarded with several prices for his research, including the Rising Star Award of the European Foundation for the Study of Diabetes (EASD).

Cora Weigert

Cora Weigert is Professor of Molecular Diabetology at the Medical Clinic in Tübingen and at the Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Germany. Her research focusses on mechanisms regulating the metabolic adaptation to physical exercise as they are key factors in the prevention of type 2 diabetes. Combining molecular biological and “Omics” technologies (transcriptomics, proteomics, metabolomics, lipidomics) exercise-regulated myokines, hepatokines as well as metabolites are studied in primary human muscle cells, mouse exercise models and human exercise intervention studies.

Fausto Machicao PhD.,MSc.Msc.

1963 Study of Chemistry ETH Zurich Switzerland and Maximilian Ludwig University Munich Germany MLU Munich Germany.1968 Molecular Genetic Maximilian Ludwig University Munich Germany. 1972 PhD. Max Planck Institute of Biochemistry Proceptor Prof A. Butenandt (Nobel laurate). 1984 Head of Biochemical Departament of Research Group Diabetes of the University Munich. 1992 Director Experimental Development Drug Research Nycomed Oslo/Norwey . 2004 Head of Laboratory for Molecular Genetic and Diagnosis at Deparment of Internal Medicine University Tübingen.
Research Interest: Diabetes: Molecular Mechanism and Genetic of type 2 Diabetes.

Andreas Peter">

Andreas Peter

Current position: Head of the Central Laboratory at the University Hospital in Tübingen and the "DZD clinical chemistry laboratory" at the Institute for Diabetes Research and Metabolism (IDM), Tübingen. Academic Education and Positions:1996-2003 Medical School in Würzburg, Sydney, Kathmandu and Zürich / 1999-2000 Research fellowship with Joel F. Habener, Laboratory of Molecular Endocrinology, Massachusetts General Hospital, HHMI, Harvard Medical School, Boston, USA / 2011 Consultant, Laboratory Medicine and Clinical Chemistry, Head of the Central Laboratory at the University Hospital of Tübingen / 2014 MHBA (Master of Health Business Administration) at the University Erlangen-Nürnberg / 2016 Appointed full Professor (W3) at the Medical Faculty of the University of Tübingen.
Research Interests: Hepatic Lipid Metabolism, Role of the Liver in the Pathophysiology of Diabetes, Novel Biomarkers

PD Dr. Konstantinos Kantartzis

Konstantinos Kantartzis received his MSc and MD in endocrinology and metabolism from the University of Athens, Greece, and his Habilitation at the University of Tübingen, Germany. He is consultant in Internal Medicine and member of the Clinical Research Team in the Department of Endocrinology, Diabetology, Nephrology, Vascular Medicine and Clinical Chemistry and in the Paul-Langerhans-Institute for Diabetes Research and Metabolic Diseases, Member of the German Centre for Diabetes Research, at the University of Tübingen, Germany. His research interests include prevention of type 2 diabetes and the impact of adiposity and body fat distribution, in particular fat accumulation in the liver (fatty liver, NAFLD), on the production and action of adipokines and hepatokines, and eventually on insulin sensitivity.

Hans-Ulrich Häring

PROFESSIONAL EXPERIENCE: Present Position: Head of the IVth Medical Department, University of Tübingen Chair of Internal Medicine, Endocrinology, Diabetes, Angiology, Nephrology and Clinical Chemistry 1986-1996: Head of the Clinical Experimental Department, Institute for Diabetes Research and Oberarzt, IIIrd Medical Department of the Schwabing City Hospital 1983 - 1986: IIIrd Medical Department of the Schwabing City Hospital and Institute for Diabetes Research 1982-1983: Post doctoral fellowship at the Joslin Diabetes Research Laboratories, Harvard Medical School, Boston 1977-1981: Institute of Diabetes Research, Munich

Angela Lehn-Stefan

Academic degree: MD Current position: Consultant/Senior Physician for Internal Medicine at the Department of Internal Medicine IV, Divisions of Diabetology & Endocrinology, Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen Otfried-Müllerstr. 10 72076 Tübingen, Germany
Education: 1991-1997 Medical School, University of Tübingen, Germany / 1997 Doctoral Thesis / 1997-1998 Physician, Internal Medicine, Städtisches Klinikum Esslingen, Germany / 1998-2000 Physician, Internal Medicine, Kreiskrankenhaus Nürtingen, Germany / 2000-2001 Physician, Internal Medicine, Medizinsche Universitätsklinik Tübingen / 2001-2002 Research Fellow, NIH/NIDDK, Phoenix, AZ, USA / 2003- Physician, Internal Medicine, Medizinsche Universitätsklinik Tübingen/ 2009 Specification in Internal Medicine / 2010 Specification in Angiology / 2011- Consultant/Senior Physician, Internal Medicine, Medizinsche Universitätsklinik, Tübingen

Norbert Stefan

Professor Norbert Stefan, MD, PhD, is holder of the Chair and the W3 Heisenberg Professorship for Clinical and Experimental Diabetology, Department of Internal Medicine IV, University Hospital of Tübingen, Germany. He is also Head of the Department of Pathophysiology of Prediabetes at the Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Zentrum München at the University of Tübingen, Germany. Professor Stefan's scientific interest is to understand the pathogenesis of prediabetes and type 2 diabetes and hereby focuses predominantly on the role of NAFLD, hepatokines and body fat distribution in this process.

Erwin Schleicher

After a post-doctoral fellowship at the Department of Medicinal Chemistry (Purdue University, Indiana, USA) he joined the Department of Clinical Chemistry and Diabetes Research Group at the University Clinic in Munich. In 1991 he became Director of the Diabetes Research Group. From 1996 he served as head and vice head of Clinical Chemistry/Central Laboratory at the University Hospital Tübingen. His major scientific interests are: i) the molecular mechanism of insulin signal transduction and its impairment leading to type 2 diabetes, ii) the pathogenesis of diabetic vascular lesions including the involvement of the AGE-RAGE-axis iii) the search for biomarkers predicting the development of diabetes and its complications

Harald Staiger

Academic career: 1988-1993 Studies of biology, University of Regensburg / 1993-1998 PhD thesis, University of Regensburg /1998-2007 Postdoc, Universities of Regensburg, Aachen, Tübingen / 2007 Postdoctoral thesis, University of Tübingen / 2007-2016 Lecturer, University of Tübingen / 2011 ongoing Scientific coordinator, head of department, Institute for Diabetes Research and Metabolic Diseases Tübingen / 2016 ongoing Associate professor, University of Tübingen
Scientific achievements / 2006-2018 Editorial board member, International Journal of Adipose Tissue, Peer J, PLoS One / 2017 ongoing Editor-in-chief, Experimental and Clinical Endocrinology & Diabetes / 2013 ongoing Research coordination board member, German Center for Diabetes Research

Susanne Ullrich

1981 Diploma in Biology, University of Constance, Germany / 1986 PhD at the Institute of Clinical Biochemistry of the University of Geneva, Switzerland
1994 Habilitation fellowship of the DFG / 1996 Habilitation at the Institute of Physiology, University of Freiburg, Germany / 1997 Heisenberg Fellowship of the DFG
2006 Research group leader at the Department of Internal Medicine, University Hospital of Tübingen, Germany / 2014 Head of the DZD Islet Facility at the IDM
2010 Member of AkademiaNet (excellence network of female scientists) / 2017 Member of the steering committee of the EASD islet Study Group

Baptist Gallwitz

Prof. Baptist Gallwitz is deputy head of the department for Endocrinology, Diabetes and Metabolism at the University of Tübingen, Germany and Past President of the German Diabetes Association. Baptist Gallwitz is board certified in Internal Medicine with a further specialisation in Gastroenterology and Endocrinology.
His scientific focus is on the physiology of incretin hormones. He has been awarded a respectable number of awards and prizes including the Werner Creutzfeldt Prize awarded by the DDG for scientific work in the field of incretin hormones. He is also co-editor of the German standard textbook for clinical diabetology.

Ferruh Artunc

University: Oct./94-Dec./01 Medical School, Eberhard-Karls-University in Tübingen/Germany / Doctoral thesis: Nov./97-Oct./99 Start at the Pharmacological and Toxicological Institute of the University Of Tübingen / Nov./98-März/99 Local Scholarship by IZKF Tübingen Profession: Jan./02- Sept./04 Residency at the University Hospital Of Tuebingen, Department Of Internal Medicine III (Cardiology/Nephrology) / Oct./04-Mar ´06 Research Fellow at the Department Of Physiology, University Of Tuebingen / April ´06 - Continued residency at the University Hospital Tuebingen, Department Of Internal Medicine IV (Endocrinology /Nephrology) / Mar ´09 Specialisation in Internal Medicine / Jan ´10 Associate Professor for Internal Medicine / Dec ´10 Subspecialisation Nephrology / Jan ´13 Subspecialisation Hypertensiology / April ´14 Professor for Internal Medicine/Nephrology

HOTEL	ACCOMMODATION TYPE (double rooms)	PRICE PER ROOM/NIGHT In EUR	BOARD	MINIMUM STAY
ELECTRA PALACE www.electrahotels.gr/el/thessaloniki/electra-palace-thessaloniki	PREMIUM ROOM	210	BREAKFAST	2 NIGHTS
	SUPERIOR SEA VIEW	230	BREAKFAST	2 NIGHTS
MAKEDONIA PALACE www.makedoniapalace.com	PREMIUM CITY VIEW	190	BREAKFAST	2 NIGHTS
MAKEDONIA PALACE www.makedoniapalace.com	PREMIUM SEA VIEW	210	BREAKFAST	2 NIGHTS
MEDITERRANEAN PALACE www.mediterranean-palace.gr	CITY VIEW	150	BREAKFAST	2 NIGHTS
MEDITERRANEAN PALACE www.mediterranean-palace.gr	SEAVIEW	165	BREAKFAST	2 NIGHTS
CITY www.cityhotel.gr	INNER VIEW	130	BREAKFAST	2 NIGHTS
CITY www.cityhotel.gr	CITY VIEW	140	BREAKFAST	2 NIGHTS
EGNATIA PALACE www.egnatiapalace.gr/en	CITY VIEW	110	BREAKFAST	2 NIGHTS

18 - 20 Μαΐου 2018